Bed time NPH-insulin plus combined sulfonylurea-biguanide oral therapy for treating refractory non insulin dependent diabetic patients.
di Cianni
G
G
Benzi
L
L
Ciccarone
A M
AM
Cecchetti
P
P
Navalesi
R
R
D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000097:blood; D003920:Diabetes Mellitus / Q000097:blood / Q000178:diet therapy / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005934:Glucagon; D005905:Glyburide / Q000008:administration & dosage / Q000627:therapeutic use*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007336:Insulin, Isophane / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D009765:Obesity; D010629:Phenformin / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D015431:Weight Loss
D001786:Blood Glucose; D002096:C-Peptide; D005934:Glucagon; D005905:Glyburide; D006442:Glycated Hemoglobin; D007336:Insulin, Isophane; D010629:Phenformin